FDA.reportPublic FDA data

NDC 47426-302-06 - ZYNRELEF

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
47426-302
Requested NDC
47426-302-06
Package NDCs from labels
47426-302-06, 47426-302-04, 47426-302-02
Manufacturer
Heron Therapeutics, Inc. | Lifecore Biomedical | Apitoria Pharma, Ltd. | Cambrex Karlskoga AB | Pharma Packaging Solutions
Effective date
2026-04-20
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
ZYNRELEFHeron Therapeutics, Inc. | Lifecore Biomedical | Apitoria Pharma, Ltd. | Cambrex Karlskoga AB | Pharma Packaging Solutions2026-04-20HUMAN PRESCRIPTION DRUG LABEL

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
47426-302-022024-09-18C16284748780-11e7a6dab-1ec9-a2ce-e063-dadaa90aadf7These highlights do not include all the information needed to use ZYNRELEF ® safely and effectively. See full prescribing information for ZYNRELEF. ZYNRELEF (bupivacaine and meloxicam) extended-release solution, for instillation use Initial U.S. Approval: 2021
47426-302-022024-07-30C16284748780-11e7a6dab-1ec9-a2ce-e063-dadaa90aadf7These highlights do not include all the information needed to use ZYNRELEF ® safely and effectively. See full prescribing information for ZYNRELEF. ZYNRELEF (bupivacaine and meloxicam) extended-release solution, for instillation use Initial U.S. Approval: 2021

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
47426-302-02ZYNRELEF1 in 1 KITSOLUTION116
47426-302-04ZYNRELEF1 in 1 CARTONSOLUTION116
47426-302-06ZYNRELEF10.5 mL in 1 VIAL, SINGLE-DOSESOLUTION10.516

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
47426-302ZYNRELEF (BUPIVACAINE AND MELOXICAM) SOLUTION [HERON THERAPEUTICS, INC.]13Legacy NDC, 3 package rows20241206_dab484a7-9353-43ba-9e74-7fab910c712b.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 6 of 7 · 124 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
MELOXICAMMELOXICAMCamber Pharmaceuticals, Inc.5265e241-ab6a-400f-809f-5992f36c55932024-08-16Boxed warning, Warnings, Adverse reactionsExact identifier
unii: VG2QF83CGL
MELOXICAMMELOXICAMBryant Ranch Prepacke5860527-f338-4073-9bb4-9f5f079469e72024-08-08Boxed warning, Warnings, Adverse reactionsExact identifier
unii: VG2QF83CGL
meloxicamMELOXICAMBryant Ranch Prepack3e37bece-b23e-41ca-9557-5105087e273b2024-08-08Boxed warning, Warnings, Adverse reactionsExact identifier
unii: VG2QF83CGL
MeloxicamMELOXICAMLupin Pharmaceuticals, Inc.06a401f0-4380-4081-86ed-a309a25abf6b2024-08-08Boxed warning, Warnings, Adverse reactionsExact identifier
unii: VG2QF83CGL
meloxicamMELOXICAMUnichem Pharmaceuticals (USA), Inc.5fe76337-eae5-4e5c-96ef-6cfa97983c6e2024-08-05Boxed warning, Warnings, Adverse reactionsExact identifier
unii: VG2QF83CGL
meloxicamMELOXICAMNuCare Pharmaceuticals, Inc.4925f194-c924-242c-e054-00144ff88e882024-07-16Boxed warning, Warnings, Adverse reactionsExact identifier
unii: VG2QF83CGL
meloxicamMELOXICAMNuCare Pharmaceuticals,Inc.630221ef-714e-6996-e053-2991aa0a586f2024-07-16Boxed warning, Warnings, Adverse reactionsExact identifier
unii: VG2QF83CGL
BupivacaineBUPIVACAINEJiangsu Hengrui Pharmaceuticals Co., Ltd.0af296bb-1599-4b35-b66b-994924d3e8982024-07-09Warnings, Adverse reactionsExact identifier
unii: Y8335394RO
MELOXICAMMELOXICAMProficient Rx LP3cc9741f-0574-485f-bbf5-027cb236736c2024-06-01Boxed warning, Warnings, Adverse reactionsExact identifier
unii: VG2QF83CGL
MELOXICAMMELOXICAMAiPing Pharmaceutical, Incf93806e1-88b8-4bcd-ac29-7642ab4d6cbd2024-05-02Boxed warning, Warnings, Adverse reactionsExact identifier
unii: VG2QF83CGL
meloxicamMELOXICAMA-S Medication Solutionseb5834e0-c6db-4d0f-ae37-9ba2e1aabfdf2023-11-26Boxed warning, Warnings, Adverse reactionsExact identifier
unii: VG2QF83CGL
meloxicamMELOXICAMA-S Medication Solutionsbcfca8c6-bdba-4546-97be-1fc5601c73462023-09-19Boxed warning, Warnings, Adverse reactionsExact identifier
unii: VG2QF83CGL
MELOXICAMMELOXICAMNCS HealthCare of KY, LLC dba Vangard Labs108397e9-672d-4061-bb74-65818c782d612023-03-07Boxed warning, Warnings, Adverse reactionsExact identifier
unii: VG2QF83CGL
meloxicamMELOXICAMAsclemed USA, Inc.49367275-4bff-4e36-8a91-e59eb07aa15f2022-10-05Boxed warning, Warnings, Adverse reactionsExact identifier
unii: VG2QF83CGL
MeloxicamMELOXICAMAphena Pharma Solutions - Tennessee, LLCe1603665-bbce-48b3-9424-3646570ae9b82022-08-17Boxed warning, Warnings, Adverse reactionsExact identifier
unii: VG2QF83CGL
MeloxicamMELOXICAMProficient Rx LPb5d72a30-3d32-45ad-be81-3fe601d8912b2022-04-01Boxed warning, Warnings, Adverse reactionsExact identifier
unii: VG2QF83CGL
MeloxicamMELOXICAMAphena Pharma Solutions - Tennessee, LLC432c3937-a4fe-4c92-8452-9ed2dd2cfc9a2022-03-03Boxed warning, Warnings, Adverse reactionsExact identifier
unii: VG2QF83CGL
MeloxicamMELOXICAMAphena Pharma Solutions - Tennessee, LLC9392df66-a152-40e6-b43b-44dc46a234962021-08-10Boxed warning, Warnings, Adverse reactionsExact identifier
unii: VG2QF83CGL
meloxicamMELOXICAMAphena Pharma Solutions - Tennessee, LLC10c3949c-0066-4b8a-8d35-937e1ce09bf82021-08-06Boxed warning, Warnings, Adverse reactionsExact identifier
unii: VG2QF83CGL
MeloxicamMELOXICAMAphena Pharma Solutions - Tennessee, LLC8f43b954-d1cb-4210-b479-5292c446cc742021-05-20Boxed warning, Warnings, Adverse reactionsExact identifier
unii: VG2QF83CGL

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.